Biocon unveils India’s first 24-hour diabetes drugMay 29th, 2009 - 9:24 pm ICT by IANS
Bangalore, May 29 (IANS) Biotechnology firm Biocon Ltd Friday unveiled a new drug to help diabetics control their blood sugar levels.
The product, Basalog, is the first diabetic drug whose effect lasts a full 24 hours, Biocon chief Kiran Mazumdar-Shaw told reporters here.
The drug will be available in Indian market from Saturday in 10ml and 3ml vials.
Basalog is effective for both type one and type two diabetics, Mazumdar-Shaw said.
“Diabetes is a debilitating disease, affecting global population like a pandemic. Sadly India is the epicentre of the disease. Basalog is part of Biocon’s commitment to provide best of diabetes management and care in India,” she said.
“The prominent feature of Basalog is that it has 24-hour long peek less action, the first in the country. It ensures effective HbA1c control and has flexibility of injection timing, unlike other insulin,” added Mazumdar-Shaw.
HbA1c is a diagnostic test to ascertain the patient’s blood glucose level for a three-month period.
According to statistics, India has the largest diabetic population in the world with around 40 million people.
Currently, there would be around 200-230 million diabetics in the world.
“Biocon’s research efforts over the years have yielded many important bio-therapeutics for diabetes and other life threatening diseases. Basalog is truly a life changing drug for diabetes management that has an effect of 24-hour duration,” said Rakesh Bamzai, president-marketing of Biocon.
“The drug is also priced at an affordable rate for Indian patients,” he added.
The price of 10ml vial is Rs.2,500.
- Biocon ties up with Pfizer to market biosimilars - Oct 18, 2010
- Scientists uncover gut bug link to type 2 diabetes - Mar 14, 2012
- Pfizer snaps insulin marketing deal with Biocon - Mar 13, 2012
- Structured exercise training helps lower diabetics' blood sugar - May 04, 2011
- Nicotine raises blood sugar among diabetic smokers: Study - Mar 28, 2011
- Biocon, US firm to jointly make drug for diabetes - Sep 11, 2009
- Exenatide - a physiological option for a pathological disease. - Sep 17, 2009
- Biocon's Mazumdar-Shaw backs Bt brinjal cultivation - Jan 19, 2010
- Combining aerobic and resistance training helpful for diabetics - Nov 24, 2010
- Blood glucose levels indicator of retinopathy risk - Feb 15, 2011
- Obstructive sleep apnea 'can make diabetes worse' - Jan 15, 2010
- Karnataka denies ban on clinical drug trials - May 04, 2011
- Intense diabetes treatment could make sugar levels go 'too low' - Jan 27, 2010
- Hemoglobin A1c test better indicator of diabetes risk - Mar 04, 2010
- Indian-origin expert explains failure of first inhaled insulin product - Sep 24, 2009
Tags: 10ml, 3ml, biotechnology firm, blood glucose level, blood sugar levels, diabetes drug, diabetes management, diabetic drug, diabetic population, diabetics, diagnostic test, epicentre, global population, indian patients, insulin, life threatening diseases, pandemic, president marketing, research efforts, vials